It has been revealed that the maker of a powerful, addictive opioid drug is bankrolling the opposition to the effort to legalize and regulate marijuana for recreational use in Arizona.
The Phoenix New Times reported Thursday that Insys Therapeutics, the company behind the fentanyl-based medication Subsys, made a $500,000 donation to the group Arizonans for Responsible Drug Policy (ARDP), which is leading the campaign against Proposition 205.
On the ballot in November, Prop. 205 would allow people 21 years of age or older to possess up to one ounce of marijuana and grow up to six plants in their homes as well as establish a department to regulate the drug's cultivation and sale.
It appears that Insys is trying to "eliminate the competition," according to the New Times, which noted that the company "expects to soon launch a pharmaceutical version of THC, the main psychoactive ingredient in cannabis."
What's more, Insys is currently facing numerous state investigations for deceptively marketing and selling Subsys, which is intended to treat cancer pain, and coercing doctors to promote it to patients for off-label uses. Fentanyl is estimated to be 80 times as potent as morphine and hundreds of times more potent than heroin, according to the Centers for Disease Control and Prevention, and may be fatal to users.
"It's hard to imagine a more sinister donor than Insys Therapeutics Inc. in the eyes of pot legalization proponents, who long have claimed drug companies want to keep cannabis illegal to corner the market for drugs, some addictive and dangerous, that relieve pain and other symptoms," U.S. News & World Report wrote Thursday, summarizing the dynamic.
Responding to the news, J.P. Holyoak, chair of the Prop. 205 proponent group Campaign to Regulate Marijuana Like Alcohol, issued a press statement slamming the opposition to keeping the donation from "one of the more unscrupulous members of Big Pharma."
"You have a company using profits from the sale of what has been called 'the most potent and dangerous opioid on the market' to prevent adults from using a far less harmful substance," Holyoak said.
He also pointed out their development of synthetic 'pharmaceutical cannabinoids,' and said, "It appears they are trying to kill a non-pharmaceutical market for marijuana in order to line their own pockets."
"Our opponents have made a conscious decision to associate with this company. They are now funding their campaign with profits from the sale of opioids — and maybe even the improper sale of opioids," Holyoak continued. "Any time an ad airs against Prop. 205, the voters should know that it was paid for by highly suspect Big Pharma actors."
Imagine going to the polls on Election Day and discovering that your ballot could be collected and reviewed by the
ACLU Blueprints Offer Vision to Cut US Incarceration Rate in Half by Prioritizing 'People Over Prisons' 
"These disasters drag into the light exactly who is already being thrown away," notes Naomi Klein 
How about some good news? Kansas Democratic Representative advances bill for Native Peoples. 
What mattered was that he showed up — that he put himself in front of the people whose opinions on
On a night of Democratic victories, one of the most significant wins came in Virginia, where the party held onto
A seismic political battle that could send shockwaves all the way to the White House was launched last week in
In an interview with Reuters conducted a month after he took office, Donald Trump asserted that the U.S. had “fallen
Attorney General Jeff Sessions overturned the sweeping criminal charging policy of former attorney general Eric H. Holder Jr. and directed
The news that the White House and Republican congressional leaders have given up on passing the Trans-Pacific Partnership (TPP) is
If you read the headlines, Donald Trump’s election has killed the Trans-Pacific Partnership (TPP). The headlines have it wrong. 
Democratic senator from Massachusetts offers fresh criticism of trade deal in new video 
Today’s World Trade Organization (WTO) ruling against the U.S. country-of-origin meat labels (COOL) that consumers rely on to make informed
Negotiations on the Trans-Pacific Partnership—a trade agreement between 12 nations—ended earlier this week. The likely passage of the agreement means
'For thousands of women to die unnecessary of breast cancer because of the TPP is a horrible, cruel, premeditated, and
A razor-thin Senate vote Tuesday put President Obama on the cusp of claiming victory for his ambitious international trade agenda,
The Fast Track trade authority package was rejected Friday because two years of effort by a vast corporate coalition, the
It just doesn't get more cynical than this. Note that we're talking about a bipartisan trade deal, thanks to 14